Boston Scientific Corporation Share Price

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse 21:00:02 07/05/2024 BST After market 13:10:34
73.43 USD +1.21% Intraday chart for Boston Scientific Corporation 73.75 +0.44%
Sales 2024 * 15.98B 1,281B Sales 2025 * 17.55B 1,407B Capitalization 108B 8,655B
Net income 2024 * 2.19B 176B Net income 2025 * 2.72B 218B EV / Sales 2024 * 7.13 x
Net Debt 2024 * 6.06B 486B Net Debt 2025 * 3.7B 296B EV / Sales 2025 * 6.36 x
P/E ratio 2024 *
50.1 x
P/E ratio 2025 *
40.7 x
Employees 48,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.65%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.21%
1 week+2.17%
Current month+2.17%
1 month+7.10%
3 months+12.57%
6 months+40.75%
Current year+27.02%
More quotes
1 week
70.97
Extreme 70.97
73.50
1 month
66.80
Extreme 66.8
74.39
Current year
57.11
Extreme 57.11
74.39
1 year
48.35
Extreme 48.35
74.39
3 years
34.98
Extreme 34.98
74.39
5 years
24.10
Extreme 24.1
74.39
10 years
11.10
Extreme 11.1
74.39
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 16/10/11
Director of Finance/CFO 58 30/11/96
Chief Tech/Sci/R&D Officer - 31/08/09
Members of the board TitleAgeSince
Director/Board Member 71 12/07/16
Director/Board Member 61 22/06/21
Director/Board Member 69 31/03/15
More insiders
Date Price Change Volume
07/05/24 73.43 +1.21% 4,151,544
06/05/24 72.55 -0.41% 4,922,960
03/05/24 72.85 +1.14% 7,452,084
02/05/24 72.03 -0.25% 7,610,487
01/05/24 72.21 +0.47% 6,021,096

Delayed Quote Nyse, May 07, 2024 at 09:00 pm

More quotes
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
73.43 USD
Average target price
81.16 USD
Spread / Average Target
+10.53%
Consensus